You are now leaving the Kedrion Corporate site. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it. In addition as per local health authority Regulations, some of our products are not approved for sales, marketing or distribution in all countries.
NEWS / EVENTS / .........

EVENTS - 27-10-2008

Viral Risk Assessment: Kedrion wins the SIMTI award

As part of the XXXVIII National Conference on Transfusion Medicine, the Scientific Committee of SIMTI (Italian Society of Transfusion and Immunohaematologic Medicine) has selected, as the winner for the session “transfusion-transmitted diseases”, the presentation Viral Risk Assessment - Modello Kedrion: applicazione nell’ambito del plasma italiano destinato alla lavorazione industriale (Viral Risk Assessment – Kedrion’s model: application of Italian plasma for industrial processing) (authors: Elisabetta Tosi, Tommaso Paoli, Elisa Moretti, Angela Caffarena, Claudia Nardini).

The Kedrion’s model – the result of a cooperation between groups from different backgrounds and positions, Industrial Development and Research Group (in this case, NAT Development, Nucleic Acid Amplification Techniques, and Process and Test Development) and Quality Assurance Group (Plasma Release QA Department) – has been judged to be an interesting application of mathematical models for the assessment of infection-related transfusion risks ordinarily involved in the transfusion of labile products to plasma derived products.

For more information please contact: